| Catherine Wesson Brock, OTR/L | |
|
151 Fly Creek Ave Ste 438, Fairhope, AL 36532-8309 | |
| (251) 928-9619 | |
| (251) 928-9621 |
| Full Name | Catherine Wesson Brock |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapy |
| Experience | 32 Years |
| Location | 151 Fly Creek Ave Ste 438, Fairhope, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841447463 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | OT19519 (Florida) | Secondary |
| 225X00000X | Occupational Therapist | 0615 (Alabama) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Benchmark Physical Therapy Of Alabama, Llc | 5698930444 | 74 |
News Archive
President Obama, in his address to a joint session of Congress tonight, stated that "defensive medicine" does contribute to unnecessary costs in healthcare and will now explore options for medical liability reform. The American Association of Neurological Surgeons (AANS) and Congress of Neurological Surgeons (CNS) applaud the President's inclusion of this key element as lawmakers move forward with an overall healthcare reform plan.
Young cancer patients at the crossroads of childhood and adulthood seem to be stuck in a treatment impasse. A study to be presented at the ESMO 2018 Congress in Munich, has highlighted the existence of barriers to the inclusion of 12 to 25-year-olds in both adult and pediatric early phase clinical trials, suggesting a need for more tailored approaches to give this patient population better access to therapeutic innovation.
Comprehensive health reform proposals now before Congress could help the more than 13 million uninsured young adults ages 19-29 gain coverage, and such reforms would also help ensure that those who now have coverage would not lose it, according to a new Commonwealth Fund report.
Lotus Tissue Repair, Inc. today announced the closing of a $26 million Series A financing led by Third Rock Ventures. Proceeds of the financing will be used to advance the company's proprietary recombinant collagen type VII (rC7) technology as the first and only protein replacement therapy in development for the treatment of dystrophic epidermolysis bullosa (DEB), an orphan disease that causes devastating skin blisters, morbidity and early mortality.
› Verified 5 days ago
| Provider Name | Agilitas Usa Inc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1962417444 PECOS PAC ID: 3375454648 Enrollment ID: O20120523000672 |
News Archive
President Obama, in his address to a joint session of Congress tonight, stated that "defensive medicine" does contribute to unnecessary costs in healthcare and will now explore options for medical liability reform. The American Association of Neurological Surgeons (AANS) and Congress of Neurological Surgeons (CNS) applaud the President's inclusion of this key element as lawmakers move forward with an overall healthcare reform plan.
Young cancer patients at the crossroads of childhood and adulthood seem to be stuck in a treatment impasse. A study to be presented at the ESMO 2018 Congress in Munich, has highlighted the existence of barriers to the inclusion of 12 to 25-year-olds in both adult and pediatric early phase clinical trials, suggesting a need for more tailored approaches to give this patient population better access to therapeutic innovation.
Comprehensive health reform proposals now before Congress could help the more than 13 million uninsured young adults ages 19-29 gain coverage, and such reforms would also help ensure that those who now have coverage would not lose it, according to a new Commonwealth Fund report.
Lotus Tissue Repair, Inc. today announced the closing of a $26 million Series A financing led by Third Rock Ventures. Proceeds of the financing will be used to advance the company's proprietary recombinant collagen type VII (rC7) technology as the first and only protein replacement therapy in development for the treatment of dystrophic epidermolysis bullosa (DEB), an orphan disease that causes devastating skin blisters, morbidity and early mortality.
› Verified 5 days ago
| Provider Name | Benchmark Physical Therapy Of Alabama, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1659642916 PECOS PAC ID: 5698930444 Enrollment ID: O20120629000400 |
News Archive
President Obama, in his address to a joint session of Congress tonight, stated that "defensive medicine" does contribute to unnecessary costs in healthcare and will now explore options for medical liability reform. The American Association of Neurological Surgeons (AANS) and Congress of Neurological Surgeons (CNS) applaud the President's inclusion of this key element as lawmakers move forward with an overall healthcare reform plan.
Young cancer patients at the crossroads of childhood and adulthood seem to be stuck in a treatment impasse. A study to be presented at the ESMO 2018 Congress in Munich, has highlighted the existence of barriers to the inclusion of 12 to 25-year-olds in both adult and pediatric early phase clinical trials, suggesting a need for more tailored approaches to give this patient population better access to therapeutic innovation.
Comprehensive health reform proposals now before Congress could help the more than 13 million uninsured young adults ages 19-29 gain coverage, and such reforms would also help ensure that those who now have coverage would not lose it, according to a new Commonwealth Fund report.
Lotus Tissue Repair, Inc. today announced the closing of a $26 million Series A financing led by Third Rock Ventures. Proceeds of the financing will be used to advance the company's proprietary recombinant collagen type VII (rC7) technology as the first and only protein replacement therapy in development for the treatment of dystrophic epidermolysis bullosa (DEB), an orphan disease that causes devastating skin blisters, morbidity and early mortality.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Catherine Wesson Brock, OTR/L 1200 Corporate Dr Ste 400, Hoover, AL 35242-5424 Ph: (423) 238-7217 | Catherine Wesson Brock, OTR/L 151 Fly Creek Ave Ste 438, Fairhope, AL 36532-8309 Ph: (251) 928-9619 |
News Archive
President Obama, in his address to a joint session of Congress tonight, stated that "defensive medicine" does contribute to unnecessary costs in healthcare and will now explore options for medical liability reform. The American Association of Neurological Surgeons (AANS) and Congress of Neurological Surgeons (CNS) applaud the President's inclusion of this key element as lawmakers move forward with an overall healthcare reform plan.
Young cancer patients at the crossroads of childhood and adulthood seem to be stuck in a treatment impasse. A study to be presented at the ESMO 2018 Congress in Munich, has highlighted the existence of barriers to the inclusion of 12 to 25-year-olds in both adult and pediatric early phase clinical trials, suggesting a need for more tailored approaches to give this patient population better access to therapeutic innovation.
Comprehensive health reform proposals now before Congress could help the more than 13 million uninsured young adults ages 19-29 gain coverage, and such reforms would also help ensure that those who now have coverage would not lose it, according to a new Commonwealth Fund report.
Lotus Tissue Repair, Inc. today announced the closing of a $26 million Series A financing led by Third Rock Ventures. Proceeds of the financing will be used to advance the company's proprietary recombinant collagen type VII (rC7) technology as the first and only protein replacement therapy in development for the treatment of dystrophic epidermolysis bullosa (DEB), an orphan disease that causes devastating skin blisters, morbidity and early mortality.
› Verified 5 days ago
Mrs. Crystal Bates Rogers, OTR/L, CHT Occupational Therapist Medicare: Medicare Enrolled Practice Location: 243 Greeno Rd S, Fairhope, AL 36532 Phone: 251-928-3909 Fax: 251-928-3984 | |
Tori Lee Rowell, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 151 Fly Creek Ave Ste 438, Fairhope, AL 36532 Phone: 251-928-9619 Fax: 251-928-9621 | |
Sensory In Motion Therapy Services, Llc Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 22873 Us Highway 98, Building I, Suite 1, Fairhope, AL 36532 Phone: 251-680-3759 | |
Kendall Pharez, MS, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 9837 Us Highway 98, Fairhope, AL 36532 Phone: 251-517-7787 | |
Lynley Corley, OT Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 151 Fly Creek Ave Ste 438, Fairhope, AL 36532 Phone: 251-928-9619 Fax: 251-928-9621 | |
Mrs. Kori Morgan Vessell, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 9837 Us Highway 98, Fairhope, AL 36532 Phone: 251-517-7787 | |
Cynthia G Powell, OT Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 351 S Greeno Rd, Fairhope, AL 36532 Phone: 251-928-7312 Fax: 251-928-8316 |